Navigation Links
Part I. Not for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.
Date:7/18/2014

areholders of both companies, bringing the potential for strengthened sustainability of top-tier EPS growth, attractive free cash flow and enhanced cash returns to shareholders. The combination would provide us with enhanced access to cash that we can use to expand our portfolio and fund M&A to supplement organic growth."

Commenting on the Merger, Susan Kilsby, Chairman of Shire said:

"Shire has a long track record of delivering value for both shareholders and patients. Our growth profile has been accelerated under our new management team who have successfully executed a focused strategy.

We believe that this offer reflects the substantial value that we have already created for Shire's shareholders and the strength of our future prospects. We believe that the combined group represents an exciting fit of two complementary businesses that will create a new market leader in specialty pharmaceuticals with a portfolio of fast growing products, a promising pipeline and enhanced growth prospects."

This summary should be read in conjunction with the full text of the following announcement including the Appendices. The Conditions and certain further terms of the Merger are set out in Appendix I. Appendix II contains bases and sources of certain information contained within this document. Appendix III contains details of the irrevocable undertakings given to New AbbVie. Appendix IV contains the definitions of certain terms used in this announcement.There will be an investor call at 2.00pm BST / 8.00am CST. Dial-in details are set out below:
UK toll free : 0800-279-9630
US toll free : 866-617-1526
International: 001-210-795-0624
Passcode: AbbVie

Further informationThis announcement is provided for informational purposes only and does not constitute an offer to sell, or an invitation to subscribe for, purchase or exchange, any securities or the solicitation of any vote or approval in any jurisdiction, nor shal
'/>"/>

SOURCE AbbVie Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 20
2. aTyr Pharma Announces Publication of a Rare Muscle Disease Associated with Regulation of a Potential Physiocrine
3. BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
4. Micell Technologies Announces DESSOLVE I Manuscript Accepted for Publication in American College of Cardiologys Cardiovascular Interventions Journal
5. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
6. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
7. BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
8. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
9. SI-BONE, Inc. Announces Publication of Postmarket Surveillance Safety Data on First 5,319 Patients Treated with iFuse Implant System
10. Metabolic Solutions Development Company announces publication of data describing potential for new drugs to maintain pancreatic beta-cells in treating diabetes
11. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... and VANCOUVER , July 2, 2015 /PRNewswire/ ... announced today that its common shares have been approved for ... the symbol "EPIX". ESSA will begin trading on ... listing on the TSX Venture Exchange under the symbol "EPI". ... common shares on the NASDAQ, each of the Company,s outstanding ...
(Date:7/2/2015)... -- Before you head outdoors with your family to enjoy the ... healthy. Take steps to protect yourself from the sun, bugs ... Protect Your Skin From the Sun Exposure to ... of skin cancer. To protect your skin from UV radiation, ... midday hours. Wear a hat with a wide brim to ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) has announced the ... End-User & by Region - Global Trends & Forecast to ... is projected to reach about $2.5 Million by 2020, with ... opportunities in countries such as India , ... and Brazil . In 2013, the North ...
Breaking Medicine Technology:ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3
... 25, 2011 Wolters Kluwer Pharma Solutions, Inc., a ... healthcare professionals, today announced that Rep. Ben Quayle ... this week with its healthcare analytics management team to discuss ... America.  Congressman Quayle visited the company,s offices on Camelback Road ...
... 2011 Innovation, makers of PharmASSIST® pharmacy automation solutions, ... today announced that they have signed a partnership agreement ... of automated, high density robotic storage and retrieval systems ... (#782) at the upcoming NACDS Pharmacy & Technology Conference ...
Cached Medicine Technology:Congressman Quayle Talks With Wolters Kluwer Pharma Solutions About Importance of Health Information 2Congressman Quayle Talks With Wolters Kluwer Pharma Solutions About Importance of Health Information 3Innovation and RxSafe, LLC Partner to Bring Together Pharmacy Automation Product Suites 2
(Date:7/3/2015)... Lewisville, TX (PRWEB) , ... July 03, 2015 , ... ... said First Choice Emergency Room , the largest network of independent freestanding emergency ... the new facility medical director of our Sienna Plantation facility,” said Executive Medical Director ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and ... this week that he says will reveal biblical truth and expose popular lies regarding ... Your Bible Say Don’t Have Sex”, immediately goes into the core of the subject ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... sweetFrog Enterprises, ... Mississippi. The opening is the first sweetFrog store located in Mississippi. The premium frozen ... companies in 2014. , The store, located at 104 Railroad Avenue, New Albany, MS ...
(Date:7/2/2015)... ... July 02, 2015 , ... Following the recent report by ... obese Americans outnumber merely overweight Americans, Samir Becic emphatically declared a war on obesity ... society right now," Becic said. "We must understand the magnitude of this discovery. For ...
(Date:7/2/2015)... ... , ... Many Fourth of July celebrations will include fireworks this summer, so ... sharing some tips to promote the proper use of fireworks. , According to the ... daily with fireworks-related injuries in the month surrounding the Fourth of July. Amica is ...
Breaking Medicine News(10 mins):Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetfrog Opens First Location in Mississippi 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:6 Fireworks Safety Tips from Amica Insurance 2
... (Nice) said that doctors should not prescribe beta blockers ... watchdog’s said that drugs that are currently prescribed are ... the recent study it was found that beta-blockers though ... less serious side effects. ,Other treatments should ...
... now becomes more effective and safe with a newer, ... ,Tissue engineers and chemists at the University ... from simple polymers, which serve as an effective method ... ,This ultra-fine, 3-dimensional scaffold, which is made from ...
... accurately shown by an increased nighttime BP than with a ... the researchers at Uppsala University revealed that a high blood ... congestive heart failure. ,Congestive heart failure (CHF) ... diseases. Once diagnosed as having CHF, patients have a 1 ...
... found that Alzheimer’s damaged communication pathways between frontal and ... as long-term memory power. ,According to a ... Alzheimer’s disease plus recent memory loss may be linked ... ,For the first time, researchers at Duke University Medical ...
... today insisted that he and his colleague the Minister ... the Progressive Democrats Party and in Government. ... that relationship between the two Cabinet members McDowell tried ... the junior coalition partner. It was also suggested by ...
... has compiled a report on that details the top 10 ... 19 other scientists in the United States, Canada and Italy. ... on the reasons for obesity besides exercise and diet. They ... ,* Inadequate sleep: Sleep deprivation leads to some sort ...
Cached Medicine News:Health News:Fine Polymer Scaffolding – a Boon for Skin Reconstructio 2Health News:Increased Nighttime BP, a Significant Predictor of Congestive Heart Failure 2Health News:Memory Loss and Amnestic MCI – Precursors of Alzheimer Diseas 2
... CS and Alliance Catheter Delivery ... the introduction of catheters or ... from a superior approach. These ... outstanding peel-away introducer performance with ...
The AXIUS™ Blower/Mister provides controlled delivery of CO2 and saline to improve visibility during anastomosis....
... DYNALINK .018 Biliary Self-Expanding Stent System combines low-profile, ... system. This .018" guide wire compatible stent system ... in all diameters (5.0 - 10.0 mm). Now, ... is offered in five stent lengths (28, 38, ...
... comprise the world's broadest line of ... Their advanced catheter design and materials ... with a soft, atraumatic tip. Available ... Supreme and Response catheters provide outstanding ...
Medicine Products: